Everything you need to know about safely storing and preparing your Monumental Peptides research compounds for optimal stability and reliable results.
⚠️ For laboratory research reference only — not for human use
Research peptides from Monumental Peptides are supplied in lyophilised (freeze-dried) powder form. This format is used because it maximises compound stability during transit and extends shelf life by minimising exposure to heat, moisture, and light — the three primary causes of peptide degradation.
Proper handling from the moment your order arrives is critical. Following the storage and reconstitution procedures outlined in this guide will help maintain the purity and integrity of your compounds throughout your research.
All peptides from Monumental Peptides are dispatched in temperature-appropriate packaging. However, once received, they should be moved to controlled storage as soon as possible.
Avoid repeated freeze-thaw cycles. Each cycle introduces thermal stress that can accelerate degradation. If you plan to use a compound regularly, consider dividing it into smaller aliquots before freezing so you only thaw what you need.
Peptides should always be stored away from direct light. UV exposure can cleave peptide bonds and cause oxidation, particularly in compounds containing methionine, cysteine, or tryptophan residues.
Peptide stability varies depending on the compound, storage conditions, and form. The following are general guidelines applicable to most research peptides supplied by Monumental Peptides.
| Form | Storage Condition | Estimated Stability | Status |
|---|---|---|---|
| Lyophilised powder | −20 °C (freezer) | Up to 48 months | Best |
| Lyophilised powder | 2–8 °C (refrigerator) | Up to 12 months | Good |
| Reconstituted solution | 2–8 °C (refrigerator) | 2–8 weeks | Short-term |
| Reconstituted solution | −20 °C (frozen) | Up to 3 months | Acceptable |
Best practice: Keep compounds in lyophilised form for as long as possible and only reconstitute the quantity needed for your current research period. This preserves the remaining stock at peak stability.
Like all biological compounds, peptides naturally degrade over time. Understanding the stages helps researchers assess whether a compound is still suitable for use.
Minor structural changes may occur at the molecular level. At this stage, potency and purity are likely to be minimally affected and the compound may still perform reliably in controlled assays.
Loss of structural integrity begins to affect the compound's charge and conformation. Binding affinity to target receptors may be reduced. Results should be interpreted cautiously.
The peptide backbone begins to fragment into shorter chains with altered biological properties. The compound is no longer suitable for reliable in-vitro research and should be discarded.
Signs of a compromised compound: Unusual discolouration (beyond the compound's known colour — e.g. GHK-Cu is normally blue), visible particulates in solution after reconstitution, cloudiness that does not clear on gentle mixing, or an off-putting odour. Discard and do not use.
Reconstitution is the process of dissolving lyophilised peptide powder into a suitable solvent to create a research solution. Following the correct procedure protects compound integrity and ensures accurate dosing calculations.
Before you begin: Allow both the peptide vial and your chosen solvent to reach room temperature. Adding cold solvent to a cold vial can cause cloudiness and slow dissolution.
Lyophilised vials may have internal negative or positive pressure from the freeze-drying process. Draw air into a sterile syringe and insert the needle through the rubber stopper to allow pressure to equalise naturally before adding solvent. This prevents liquid being pushed back out.
Draw your chosen reconstitution solvent into a clean sterile syringe. Typical volumes are 1 mL to 2 mL for most research applications — avoid over-dilution as this can reduce stability. See solvent selection guidance below.
Insert the needle through the rubber stopper and direct the solvent flow down the inside wall of the vial rather than directly onto the lyophilised cake. This reduces foaming and mechanical disruption to the peptide structure.
Once solvent has been added, gently swirl or roll the vial between your palms until the powder is fully dissolved. Never shake vigorously — this causes foaming and can mechanically disrupt the peptide backbone, reducing compound integrity.
Hold the vial to light and check for complete dissolution. The solution should appear clear (or the compound's characteristic colour, e.g. blue for GHK-Cu) with no floating particles or cloudiness. If undissolved material remains, gentle sonication can assist.
Once reconstituted, store immediately at 2–8 °C and note the reconstitution date. Use within 2–8 weeks for best results. If freezing reconstituted solution, aliquot into single-use portions to avoid repeat freeze-thaw cycles.
The choice of reconstitution solvent affects dissolution quality, stability, and downstream research compatibility. The following are the most commonly used options.
The standard choice for most research peptides. Contains 0.9% benzyl alcohol which inhibits microbial growth, extending the usable life of reconstituted solutions. Compatible with the majority of hydrophilic peptides.
Recommended for hydrophobic peptides or those with poor water solubility. The mildly acidic environment aids dissolution. Typically used at 0.1% to 1% concentration depending on the compound.
Reserved for more hydrophobic peptides that resist standard dissolution. Used as a concentrated stock which is then diluted with the appropriate buffer for experimental protocols.
When in doubt, use bacteriostatic water. Most peptides in the Monumental Peptides catalogue are sufficiently hydrophilic to dissolve readily in BAC water at standard reconstitution volumes (1–2 mL).
If the peptide does not fully dissolve after gentle swirling, brief bath sonication (30–60 seconds) can assist. Avoid prolonged sonication as excess energy input can damage peptide structure.
For research applications requiring strict sterility, passing the reconstituted solution through a 0.2 µm syringe filter into a clean sterile vial can reduce potential bacterial contamination. Note that some peptides may bind to certain filter membranes — use low-binding PES or PVDF membranes.
For compounds you will use over an extended period, prepare a concentrated stock solution and divide into single-use aliquots in labelled microcentrifuge tubes. Freeze aliquots at −20 °C. This avoids the degradation associated with repeated freeze-thaw cycles on the same vial.
Always label reconstituted vials with the compound name, concentration (mg/mL or mcg/mL), reconstitution date, and solvent used. Good laboratory record-keeping is essential for reproducible research outcomes.
All compounds supplied by Monumental Peptides are intended strictly for in-vitro scientific research purposes by qualified laboratory professionals. This guide is provided as handling reference material for research settings only. These compounds are not approved for human or animal administration. Monumental Peptides accepts no liability for misuse of supplied compounds.